Adaptive Biotechnologies Corp Liquidation Value
ADPT
Other
Cash & Equivalents
$70.50M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $70.50M
Total Obligations: -$295.63M
$-225.13M
Per share: $-1.46
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $70.50M
AR: $50.37M
Total Obligations: -$295.63M
$-174.77M
Per share: $-1.14
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $70.50M
AR: $50.37M
Inventory: $9.82M
Total Obligations: -$295.63M
$-164.95M
Per share: $-1.07
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-225.13M | $-1.46 |
| Liquid Liquidation Value | $-174.77M | $-1.14 |
| Operating Liquidation Value | $-164.95M | $-1.07 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $70.50M |
| Accounts Receivable | $50.37M |
| Inventory | $9.82M |
| Current Liabilities | $89.92M |
| Long-term Debt | $126.57M |
| Op. Lease Liability | $79.15M |
| Finance Lease | N/A |
| Shares Outstanding | 153.8M |
Explore all 187 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $70.50M | $50.37M | $9.82M | $6.47M | $89.92M | $126.57M | $79.15M | N/A |
| 2025-09-30 | $55.03M | $44.82M | $9.93M | $10.27M | $83.36M | $129.41M | $81.80M | N/A |
| 2025-06-30 | $43.16M | $44.28M | $8.40M | $6.91M | $92.14M | $130.50M | $84.37M | N/A |
▼ Community Notes